P3.01-039 Sequential Afatinib-Osimertinib Therapy in EGFR Mutation-Positive (EGFRm+) NSCLC: Analysis of Time on Treatment and OS
Year: 2017
Type: article
Source: Journal of Thoracic Oncology
Institutions: Samsung Medical Center, Sungkyunkwan University, National Cancer Centre Singapore, Queensland University of Technology, Princess Alexandra Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, Chris O’Brien Lifehouse, Chinese University of Hong Kong, McGill University Health Centre, McGill University, National Taiwan University Hospital, Essen University Hospital, University of Duisburg-Essen, Wakayama Medical University, Harvard University, Massachusetts General Hospital, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Tongji University, Shanghai Pulmonary Hospital, Boehringer Ingelheim (Denmark), Boehringer Ingelheim (United States), Hospital Universitario 12 De Octubre
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2767807018